Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY) announced that its wholly-owned subsidiary, Roche Investments USA Inc., completed its tender offer for the publicly held shares of Genentech (NYSE: DNA).
Share
Cancer :: American Association for Cancer Research announces AACR Asia
The American Association for Cancer Research (AACR) is pleased to announce its plans to facilitate global advances in cancer research through the establishment of AACR Asia, an office that will open officially in Singapore in 2009.
Heart Disease :: Link between pre-eclampsia and heart disease
Two studies, published together on bmj.com, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.
Healthcare :: Multimedia book helps improve patient care
A new and innovative book for pediatricians is taking a different approach in helping to increase knowledge and understanding in the field of sports medicine. The book applies written information on sports medicine along with video case-based teaching to fully demonstrate the proper ways of diagnosing and treating sports related injuries in young athletes.
Medical :: NIH and India Partner to Develop Low-Cost Medical Technologies
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH), and the Department of Biotechnology (DBT) of the Ministry of Science and Technology of the Republic of India, have entered into a bilateral agreement to develop low-cost health-care technologies aimed at the medically underserved.
Genetic :: Genetic contributions to human brain morphology and intelligence
Hilleke Hulshoff Pol presents persuasive evidence how genetic factors influence the brain structure opening new insights into the reciprocal gene-environment developmental pathways.
Colorectal Cancer :: ImClone & Bristol-Myers Squibb with Merck KGaA to develop Erbitux in Japan
ImClone Systems Incorporated (Nasdaq: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced that they have established an agreement with Merck KGaA for the co-development and co-commercialization of ERBITUX(R) (cetuximab) in Japan.
Cancer :: GSK & Synta Pharmaceuticals announce development and commercialisation collaboration for STA-4783 in oncology
GlaxoSmithKline (GSK) and Synta Pharmaceuticals Corp. announced the execution of a global collaboration agreement for the joint development and commercialisation of STA-4783, a first-in-class, small-molecule, oxidative stress inducer that is entering Phase 3 clinical development for the treatment of metastatic melanoma.
Macular Degeneration :: Elevated inflammatory marker may be linked to increased risk of age-related eye disease
High blood levels of C-reactive protein, a substance linked to inflammation, appear to be associated with an increased risk for age-related macular degeneration, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Gene Therapy :: One shot of gene therapy spreads through brain
By targeting a site in a mouse brain well connected to other areas, researchers successfully delivered a beneficial gene to the entire brain—after one injection of gene therapy. If these results in animals can be realized in people, researchers may have a potential method for gene therapy to treat a host of rare but devastating congenital human neurological disorders, such as Tay-Sachs disease.